Germline mutations in BRCA1 and BRCA2 are responsible for 90% of hereditary breast cancer cases in the Western world and their mutation therefore represents the most important marker for the early detection of breast cancer.86–88 The landscape of breast cancer in the Arab world is somewhat different. This evidence concerns the gene BRCA2 and breast carcinoma.